Dr. Susan Moore

Dr. Susan Moore

BA (Geography), University of British Columbia
BSc (Microbiology), University of Victoria
PhD (Biochemistry), University of Victoria

Team: 
Associate Members
Positions: 

Laboratory Manager, Vancouver Prostate Centre
Adjunct Professor, Department of Medicine, University of British Columbia
Chairman, Vancouver Coastal Health Research Institute Joint Health & Safety Committee

 

Dr. Moore joined the VPC in 2003 as a Post-doctoral Fellow, bringing her own funding via an NSERC Fellowship and a Michael Smith Foundation Trainee Award.  She was promoted to a Research Associate in 2008; has served on the VCHRI Joint Health and Safety Committee since 2004 and as Chair since 2007; and started teaching in 2007 in the UBC Department of Medicine Undergraduate MD program where she was appointed  Adjunct Faculty in 2009.

As Lab Manager, Dr. Moore is responsible for managing day-to-day operations of the Vancouver Prostate Centre research labs.  She monitors and analyzes lab performance to ensure maximum efficiency, and ensures adherence to required regulations and effective lab supply management practices are in place.  She is the key point of contact for all equipment related responsibilities and issues.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

Fathers Day Walk Run 2019

Raymond James Father's Day Walk Run Fundraiser, June 16, 2019

The 21st Annual Raymond James Walk Run fundraiser for Prostate Cancer Foundation BC took place on Sunday June 16, 2019 in various locations across BC. The sponsorship page is still accepting donations;  click here to sponsor our Centre's team (opens in new window).

 

Employment

Work at the Vancouver Prostate Centre

Monday, July 8, 2019

Dr. Flannigan to lead clinical trial for scrotal pain treatment

Dr. Flannigan
Monday, June 3, 2019

Benefits Seen With Apalutamide Plus ADT in Metastatic Castration-Sensitive Prostate Cancer

Dr. Chi